Neuropathology of autoimmune encephalitides.
In recent years a large number of antibody-associated or antibody-defined encephalitides have been discovered. These conditions are often referred to as autoimmune encephalitides. The clinical features include prominent epileptic seizures, cognitive and psychiatric disturbance. These encephalitides can be divided in those with antibodies against intracellular antigens and those with antibodies against surface antigens. The discovery of new antibodies against targets on the surface of neurons is especially interesting since patients with such antibodies can be successfully treated immunologically. This chapter focuses on the pathology and the pathogenetic mechanisms involved in these encephalitides and discusses some of the questions that are raised in this exciting new field. It is important to realise, however, that because of the use of antibodies to diagnose the patients, and their improvement with treatment, there are relatively few biopsy or postmortem reports, limiting the neuropathological data and conclusions that can be drawn. For this reason we especially focus on the most frequent autoimmune encephalitides, those with antibodies to the NMDA receptor and with antibodies to the known protein components of the VGKC complex. Analysis of these encephalitides show completely different pathogenic mechanisms. In VGKC complex encephalitis, antibodies seem to bind to their target and activate complement, leading to destruction and loss of neurons. On the other hand, in NMDAR encephalitis, complement activation and neuronal degeneration seems to be largely absent. Instead, binding of antibodies leads to a decrease of NMDA receptors resulting in a hypofunction. This hypofunction offers an explanation for some of the clinical features such as psychosis and episodic memory impairment, but not for the frequent seizures. Thus, additional analysis of the few human brain specimens present and the use of specific animal models are needed to further understand the effects of these antibodies in autoimmune encephalitides.
Center for Brain Research, Medical University Vienna, Vienna, Austria. Electronic address: jan.bauer@meduniwien.ac.at.
Jan
J
Bauer
Epilepsy-Centre Bethel, Krankenhaus Mara, Bielefeld, Germany.
Christian G
CG
Bien
D000818:Animals; D004660:Encephalitis / Q000473:pathology*; D050031:Hashimoto Disease / Q000473:pathology*; D006801:Humans; D009420:Nervous System / Q000473:pathology*; D000069338:Neuropathology
GAD65; NMDAR; VGKC–complex; antibody-associated; complement; cytotoxic T cells; encephalitis; epilepsy; inflammation